发明名称 Cell preparation containing mesenchymal stem cells, and method for producing same
摘要 A cell preparation containing mesenchymal stem cells whose immunosuppression ability is maintained is produced by means of a serum-free or low-serum culture. A method for producing a cell preparation containing mesenchymal stem cells, comprising the steps of: (A) proliferating mesenchymal stem cells in a serum-free medium “A” containing an FGF, a PDGF, a TGF-β, an HGF, an EGF, at least one phospholipid, and at least one fatty acid; and (B) screening mesenchymal stem cells whose immunosuppression ability is maintained or improved, from the mesenchymal stem cells thus proliferated in the step (A).
申请公布号 US9394521(B2) 申请公布日期 2016.07.19
申请号 US201113583150 申请日期 2011.03.10
申请人 TWO CELLS Co., Ltd. 发明人 Tsuchiya Toshie;Tsuji Koichiro;Kato Yukio;Shao Jin Chang;Hara Maiko
分类号 C12N5/0775;C12Q1/06;A61K35/12 主分类号 C12N5/0775
代理机构 Renner, Otto, Boiselle & Sklar, LLP 代理人 Renner, Otto, Boiselle & Sklar, LLP
主权项 1. A method for producing a cell preparation containing mesenchymal stem cells, comprising the steps of: a proliferation step comprising proliferating mesenchymal stem cells in a serum-free medium containing a fibroblast growth factor (FGF), a platelet derived growth factor (PDGF), a transforming growth factor-β (TGF-β), a hepatocyte growth factor (HGF), an epidermal growth factor (EGF), at least one phospholipid, and at least one fatty acid; and a screening step comprising screening mesenchymal stem cells whose immunosuppression ability is maintained or improved, from the mesenchymal stem cells thus proliferated in the proliferation step; and a pre-proliferation step comprising before the proliferation step, culturing the mesenchymal stem cells in a serum-free medium B containing a FGF, a PDGF, an EGF, at least one phospholipid, and at least one fatty acid, the serum-free medium B does not contain a HGF and a TGF-β, a culture time period of the pre-proliferation step and the proliferation step being 48 days to 68 days, and the cell preparation comprises the mesenchymal stem cells whose immunosuppression ability is maintained or improved; wherein the mesenchymal stem cells are subcultured at least once in the pre-proliferation step.
地址 Hiroshima JP